Role of Egfl7 in Angiogenesis and Vascular Injury

Egfl7 在血管生成和血管损伤中的作用

• 批准号: 8448607
• 负责人: Heidi Stuhlmann
• 金额: $ 40.22万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-07-01 至 2016-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8448607
• 关键词: Address; Adult; Affect; Architecture; Binding; Biochemical; Biological; Blood Cells; Blood Vessels; Bone Marrow; Cardiovascular system; Cells; Chemicals; Clinic; Coculture Techniques; Development; Embryo; Embryonic Development; Endothelial Cells; Endothelium; Epidermal Growth Factor; Extracellular Matrix; Fluorouracil; Goals; Growth; Hematopoiesis; Hematopoietic; Homeostasis; Human; Injury; Ischemia; Lead; Life; Maintenance; Modeling; Molecular; Myelosuppression; Myocardial Infarction; Myocardial Ischemia; Natural regeneration; Organism; Pathologic Neovascularization; Pathologic Processes; Physiologic Neovascularization; Play; Process; Protein Binding; Proteins; Recovery; Retina; Role; Signal Transduction; Solid Neoplasm; Stem cells; Stimulus; System; Testing; Tissues; Tumor Angiogenesis; Vascular Endothelial Growth Factors; angiogenesis; autocrine; base; chemotherapy; extracellular; in vivo; injured; injury and repair; irradiation; loss of function; mouse model; notch protein; overexpression; paracrine; progenitor; repaired; response; response to injury; tumor growth; tumor vascular supply

DESCRIPTION (provided by applicant): Angiogenesis is crucial for the development of a functional circulatory system in the vertebrate embryo. Central to these processes are the endothelial cells (EC) that form a continuous layer lining the blood vessels and constitute a dynamic system that changes in response to environmental stimuli. Epidermal growth factor-like 7 (EGFL7) is expressed by EC and is present both in soluble of ECM-bound forms and may act both in an autocrine and paracrine manner. Expression in adult endothelium is low but becomes induced during physiological and pathological angiogenesis. We have previously shown that Egfl7 is a critical, pro-angiogenic regulator of angiogenesis during embryonic development and in during post-natal angiogenesis in the retina. The mechanisms by which Egfl7 signals are transduced are not well understood. However, our studies show in vivo, that EGFL7 interacts with endothelial Notch and modulates Notch intracellular signaling. Little is known about its role in response to microvascular injury and repair. The bone marrow (BM) vasculature is an ideal model to address these questions because injury and regeneration of the sinusoidal endothelium and the HSPC residing in the vascular niche can be studied in a well-defined setting. Importantly, this model is relevant for pathological angiogenesis i.e. during tissue damage, ischemia, and tumor angiogenesis. A central hypothesis of this proposal is that EGFL7 acts in response to injury of the BM vasculature to promote endothelial and hematopoietic regeneration that restores the damaged tissue. We further propose that EGFL7 acts through an autocrine mechanism to promote neoangiogenesis in response to vascular injury via cross-talk with VEGF and Notch, and that EGFL7 acts through a paracrine mechanism as an "angiocrine factor" secreted by sinusoidal EC in the BM vascular niche to promote hematopoiesis. We will test these hypotheses in three specific aims. First, we will determine the role of Egfl7 in the BM vascular niche. Second, we will investigate the molecular and biochemical basis of Egfl7 signaling in primary human EC. Third, we will identify mechanisms of EGFL7 signaling in the BM vascular niche. Endothelial cells constitute a dynamic system that changes in response to environmental stimuli, including injury of the microvasculature. Understanding how these processes are orchestrated in a living organism may lead to treatments in which endothelial cells aid the repair of damaged vessels or restrict the blood supply of tumors.

描述（由申请人提供）：血管生成对于脊椎动物胚胎中功能性循环系统的发育至关重要。这些过程的中心是内皮细胞（EC），其形成血管衬里的连续层，并构成响应于环境刺激而变化的动态系统。 表皮生长因子样7（EGFL7）由EC表达，并且以可溶性ECM结合形式存在，并且可以自分泌和旁分泌方式起作用。在成人内皮中的表达较低，但在生理和病理性血管生成过程中被诱导。我们先前已经表明，Egfl7是胚胎发育期间和出生后视网膜血管生成期间血管生成的关键促血管生成调节剂。Egfl7信号转导的机制还不清楚。然而，我们的研究表明在体内，EGFL7与内皮Notch相互作用并调节Notch细胞内信号传导。关于它在微血管损伤和修复中的作用知之甚少。骨髓（BM）血管系统是解决这些问题的理想模型，因为可以在明确的环境中研究窦内皮和位于血管龛中的HSPC的损伤和再生。重要的是，该模型与病理性血管生成相关，即在组织损伤、缺血和肿瘤血管生成期间。该提议的中心假设是EGFL7响应于BM脉管系统的损伤而起作用，以促进内皮和造血再生，从而恢复受损的组织。我们进一步提出EGFL7通过自分泌机制与VEGF和Notch相互作用，促进血管损伤后的新生血管生成，并且EGFL7通过旁分泌机制作为BM血管生态位中窦状内皮细胞分泌的“血管分泌因子”促进造血。 我们将在三个具体目标中检验这些假设。首先，我们将确定Egfl7在BM血管生态位中的作用。其次，我们将研究Egfl7信号传导在原代人EC中的分子和生化基础。第三，我们将确定EGFL7信号转导在BM血管生态位的机制。 内皮细胞构成响应于环境刺激（包括微脉管系统的损伤）而变化的动态系统。了解这些过程是如何在生物体中协调的，可能会导致内皮细胞帮助修复受损血管或限制肿瘤血液供应的治疗。